期刊文献+

KIR3DL1基因启动子亚克隆及表达调控载体的构建 被引量:1

Sub-cloning of KIR3DL1 Promoter and Construction of the Reporter Plasmid
下载PDF
导出
摘要 为研究KIR3DL1基因的表达调控机制,亚克隆KIR3DL1基因的核心启动子序列,并构建KIR3DL1基因启动子-荧光素酶报告载体,采用PCR法从含有KIR3DL1基因转录起始位点5′侧翼区的质粒中扩增KIR3DL1基因核心启动子序列,产物纯化回收后与pGEM-T easy载体连接.测序鉴定正确的重组子经限制性内切酶BglⅡ和NcoⅠ双酶切后.插入同样经BglⅡ和NcoⅠ双酶切的用于基因表达调控研究的pGL3-Basic报告载体,最终获得了长度为254bp的KIR3DL1基因启动子克隆,构建了调控荧光素酶报告基因的真核表达载体。通过酶切及基因测序的方法证实所构建的重组子是正确的,说明KIR3DL1基因启动子表达调控载体的构建是成功的。 To study the possible regulation mechanism of KIR3DL1 gene expression, a core promoter sequence of KIR3DL1 gene was sub-cloned and a KIR3DL1 promoter-luciferase reporter vector was constructed. A core promoter fragment of the KIR3DL1 5"-untranslated region was amplified by PCR. PCR products were purified and connected with pGEM-T easy vector. Authenticated by DNA sequencing, the plasmid was digested with Bgl /Nco Ⅰ and cloned into Bgl Ⅱ/Nco Ⅰ-digested pGL3-basic reporter vector. A 254 bp promoter fragment of KIR3DL1 gene was cloned into the pGL3-Basic reporter vector. The reporter plasmid was authenticated by Bgl Ⅱ/Nco Ⅰ digestion and DNA sequencing. It indicated that the KIR3DL1 promoterpGL3- Basic reportor vector was successfully constructed.
出处 《标记免疫分析与临床》 CAS 2007年第4期230-233,共4页 Labeled Immunoassays and Clinical Medicine
基金 国家自然科学基金面上项目(No.30670898) 解放军总医院苗圃基金(06MP83)
关键词 KIR3DL1基因 荧光素酶报告基因 基因表达调控 KIR3DL1 gene Luciferase reporter vector Regulation of gene expression
  • 相关文献

参考文献7

  • 1Ruggeri L, Mancusi A, Burchielli E,et al. Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation[J]. Semin Cancer Biol, 2006,16 (5) : 404-411.
  • 2Ruggeri I., Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants[J]. Science, 2002.295(5562):2097-2100.
  • 3Marsh S G, Parham P, Dupont B, et al. Killer-cell immunoglobulin like receptor (KIR) nomenclature report, 2002 [J]. Eur J Immunogenet,2003,(3):229-234.
  • 4Stewart C A, van Bergen J, Trowsdale J. Different and divergent regulation of the KIR2DL4 and KIR3DL4 promoters[J]. J Immunol, 2003,170(12): 6073-6081.
  • 5van Bergen J, Stewart C A, van den Elsen P J, et al. Structur al and functional differences between the promoters of inde pendently expressed killer cell Ig-like receptors[J]. Eur J Immunol,2005, 35(7): 2191-2199.
  • 6Martelli M F, Aversa F, Bachar-Lustig E, et al. Transplants across human leukocyte antigen barriers[J]. Semin Hematol, 2002,39(1): 48-56.
  • 7Ljunggren H G, Karre K. In search of the ‘missing self': MHC molecules and NK cell recognition[J]. Immunol Today, 1990, 11(7):237-244.

同被引文献12

  • 1高晓宁(综述),于力(审校).NK细胞KIR基因表达调控机制研究进展[J].国际输血及血液学杂志,2007,30(2):157-159. 被引量:4
  • 2Xu J, Vallejo AN, Jiang Y, et al. Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T cells. J Biol Chem, 2005,280:24277-24285.
  • 3Yawata M, Yawata N, Draghi M, et al. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med, 2006, 203:633-645.
  • 4Bethge WA, Haegele M, Faul C, et al. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity. Exp Hematol, 2006, 34:1746-1752.
  • 5Ruggeri L, Capanni M, Casucci M, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood, 1999, 94:553-339.
  • 6Ruggeri L, Mancusi A, Burchielli E, et al. Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. Semin Cancer Biol, 2006, 16:404411.
  • 7Ruggeri L, Mancusi A, Capanni M, et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood, 2007, 110:433-440.
  • 8Thompson A, van der Slik AR, Koning F, et al. An improved RT-PCR method for the detection of killer-cell immunoglobulinlike receptor (KIR) transcripts, hnmunogenetics, 2006, 58: 865 -872.
  • 9Dimova DK, Dyson NJ. The E2F transcriptional network: old acquaintances with new faces. Oncogene, 2005, 24:2810-2826.
  • 10Campanero MR, Armstrong MI, Flemington EK. CpG methylation as a mechanism for the regulation of E2F activity. Proc Natl Acad Sci U S A, 2000, 97:6481-6486.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部